ArticleThe Journal of clinical investigation2016

Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.

Yanli Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.